— Know what they know.
Not Investment Advice
Also trades as: MSB.AX (ASX) · $vol 4M · MEOBF (OTC) · $vol 0M

MESO NASDAQ

Mesoblast Limited
1W: +6.2% 1M: -9.1% 3M: -6.7% YTD: -27.4% 1Y: -21.6% 3Y: +473.0% 5Y: +7.3%
$13.18
+0.79 (+6.38%)
 
Weekly Expected Move ±7.7%
$10 $11 $12 $13 $14
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 34 · $1.7B mcap · 86M float · 0.281% daily turnover · Short 49% of daily vol
Credit Risk of going bust: lower than 59% of companies Debt: 6.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.11 (down 99.1%), Mesoblast Limited would be worth roughly what it owes.
Total debt $127.3M against a stock market value of $1.71B.
Distance to default 6.09 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $64.9M (short-term plus half of long-term), stock volatility 54.7%; Altman Z'' -1.05. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

ETF Exposure

6
ETFs Holding
Total ETF Value
0.42%
Max Weight
0.107%
Avg Weight

ETF Holdings by Value

ETFs Holding MESO

# ETF Weight Value Holdings Top 10 Wt P/E Div Yield Sector Mix
1 IBB
iShares Biotechnology ETF
0.0642% 234 50.8% -8.5 0.00%
2 FNCMX
0.0010% 2,781 57.5% 72.7 0.27%
3 APIE
ActivePassive International Equity ETF
0.0100% 532 23.4% 18.6 0.03%
4 QQQS
Invesco NASDAQ Future Gen 200 ETF
0.4168% 200 8.2% -6.1 0.01%
5 IBBQ
Invesco Nasdaq Biotechnology ETF
0.0433% 247 47.4% -0.3 0.01%
6 BIB LEV
ProShares Ultra Nasdaq Biotechnology
0.0271% 246 46.6% -0.3 0.01%
Tech Financial Healthcare Consumer Cycl. Industrials Energy

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms